Central Admixture Pharmacy Services Inc recalls midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 79
Recalled August 9, 2023 · FDA recall D-1075-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: Lack of validation data for sanitization cycles · FDA Class II
Units
621 syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Product
midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →